Supreme Court Denies Cert In Patent Eligibility Cases

January 13, 2020

Voting after Friday’s conference, the Supreme Court followed the Solicitor General’s advice and denied certiorari in Hikma Pharmaceuticals USA Inc. v. Vanda Pharmaceuticals Inc. (No. 18-817), but also denied cert. in Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC (No. 19-430), and HP Inc. v. Berkheimer (No. 18-415).

Perhaps the Court has decided its work with 35 USC § 101 is done, and the rest is up to Congress.

Authors

Courtenay C. Brinckerhoff

Practice Areas

Chemical, Biotechnology & Pharmaceutical
IP Litigation

Author(s)

A woman with short light brown hair and glasses, wearing a gray turtleneck, dark blazer, and pearl necklace, smiles in a blurred corporate law office hallway background.

Courtenay C. Brinckerhoff

cbrinckerhoff@foley.com

Washington, D.C. 202.295.4094

Related Insights

View All Posts

December 4, 2025 Foley Viewpoints

FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation

FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…

December 3, 2025 Manufacturing Industry Advisor

Made in China: What the Automotive Industry Should Know About the Global Emergence of Chinese Manufacturing of Connected Vehicles Amid Increasing U.S. Restrictions

China’s automotive industry has gone global, in no small part due to technological advancements, cost advantages, and foreign investment through joint ventures, particularly in electric vehicle (“EV”) and connected vehicle technologies.

December 3, 2025 Foley In Fashion

How Tariffs Are Reshaping Holiday Shopping Trends for Fashion, Apparel & Beauty Brands

As the holiday rush approaches, tariffs have quickly become one of the most influential forces shaping retail strategies. A wave of updated import duties is driving up costs across apparel, accessories, cosmetics and beauty packaging – creating pressures many brands are already confronting as they prepare for peak retail months.